Is Sernova Corp. a good investment? Sernova Corp. (SVA.TO) is currently trading at 0.1650 CAD.
Earnings Schedule: Sernova Corp. is expected to release its next earnings report on June 11, 2026. The market consensus estimate for Forward EPS is -0.03.
No, it does not currently pay a dividend.
Sernova Corp. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be June 11, 2026. The company currently has a trailing EPS of -0.04.
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.
| Split Date | Split Ratio to 1 |
|---|---|
| May 27, 1999 | 0.330000 |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion